- Home
- / TRACON Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
TRACON Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.1
2024-10-29
Market Capitalization
$279.4 K
2024-10-29
Revenue
$12 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7.9M | 3.4M | 8.8M | 3.0M | 346.0K | 12.0M | |||
| General and administrative expense | 5.7M | 7.9M | 7.6M | 7.3M | 7.8M | 8.0M | 17.5M | 14.0M | 6.7M |
| Operating expense total | 31.4M | 29.4M | 27.0M | 37.7M | 22.3M | 16.2M | 27.9M | ||
| Depreciation and amortization | 12.0K | ||||||||
| EBIT | (23.5M) | (26.0M) | (18.2M) | (34.7M) | (22.3M) | (16.2M) | (28.3M) | (27.9M) | (9.3M) |
| EBIT margin, % | -296.9% | -753.1% | -208.0% | -1158.0% | |||||
| Interest expense | 923.0K | 1.1M | 886.0K | 231.0K | 386.0K | 545.0K | (318.0K) | 994.0K | 7.3M |
| Net Income | (24.4M) | (27.0M) | (19.1M) | (35.0M) | (22.7M) | (16.8M) | (28.7M) | (29.1M) | (3.6M) |
| EPS | (1.4) |